
26.87 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 20.24 Today|||52-Week Range 153.41 | +1.90% Year-to-Date |
The 9 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 67.00, with a high estimate of 75.00 and a low estimate of 35.00. The median estimate represents a +149.35% increase from the last price of 26.87.
The current consensus among 9 polled investment analysts is to Buy stock in Reata Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.